← Back to Search

Exercise Group for Femoroacetabular Impingement

N/A
Waitlist Available
Led By Paul Beaule, MD, FRCSC
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with symptomatic FAI
at least 3 months of groin pain
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in baseline before exercise program and 1 year afterwards
Awards & highlights

Study Summary

This trial will test whether an exercise program can help reduce pain and improve function in people with FAI, as well as prevent further cartilage deterioration.

Who is the study for?
This trial is for individuals with femoroacetabular impingement (FAI) who have experienced groin pain for at least three months, feel more pain when their hip rotates, and have specific signs of FAI on imaging tests like an alpha angle over 60 degrees and a labral tear visible on MRI. Their condition should not be too advanced as indicated by a Tonnis grade of 0 or 1.Check my eligibility
What is being tested?
The study is testing the effectiveness of an exercise program designed specifically for patients with FAI. It aims to see if this program can reduce their pain, improve how well they move and function, and possibly slow down any worsening of hip cartilage damage.See study design
What are the potential side effects?
Since the intervention involves physical exercise, potential side effects may include muscle soreness, joint discomfort or temporary increase in existing pain due to activity. However, these are typically mild and manageable.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with symptomatic femoroacetabular impingement.
Select...
I have had groin pain for at least 3 months.
Select...
My hip joint shows minimal or no arthritis.
Select...
I experience more pain when my hip is turned.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in baseline before exercise program and 1 year afterwards
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in baseline before exercise program and 1 year afterwards for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
iHOT-33
Secondary outcome measures
EQ-5D-5L
Number of participants that receive hip surgery
Patient-reported hip pain

Side effects data

From 2009 Phase 1 & 2 trial • 152 Patients • NCT00815776
7%
Discomfort or Pain
5%
Headache
100%
80%
60%
40%
20%
0%
Study treatment Arm
Clayton Intra-aural Device (CID) Group
Mouth Splint Group
Jaw Exercise Group

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise GroupExperimental Treatment1 Intervention
The group who will exercise to manage pain.
Group II: Control GroupActive Control1 Intervention
The group who will not take part in any exercises and only have to do assessments.

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor
561 Previous Clinical Trials
2,785,596 Total Patients Enrolled
Canadian Orthopaedic FoundationOTHER
13 Previous Clinical Trials
1,501 Total Patients Enrolled
Paul Beaule, MD, FRCSCPrincipal InvestigatorOttawa Hospital Research Institute
2 Previous Clinical Trials
83 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~17 spots leftby Apr 2025